-
Trevi Therapeutics (NASDAQ:TRVI) Upgraded to Strong-Buy at Raymond James
Source: Buzz FX / 10 Mar 2025 07:27:16 America/Chicago
Trevi Therapeutics (NASDAQ:TRVI) Upgraded to Strong-Buy at Raymond James Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) was upgraded by investment analyst
Read more...